2,3,4',5-Tetrahydroxystilbene-2-O-β-d-glucoside attenuates atherosclerotic progression by inhibiting inflammation via downregulation of TNF receptor-associated factor 6 expression.
Sign Up to like & getrecommendations! Published in 2023 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202305_32441
Abstract: OBJECTIVE Atherosclerosis (As) is an inflammatory disease, and 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glucoside (TSG) has been shown to suppress inflammation. However, it is still unclear if TSG alleviates As by inhibiting inflammation. MATERIALS AND METHODS Quantitative real-time polymerase chain reaction… read more here.
Keywords: inflammation; traf6 tnf; inhibiting inflammation; expression ... See more keywords